Article

Histopathological and Clinical Features of HER2-Positive Breast Cancers across Hormone Receptor Subgroups: A Cross-Sectional Analysis

2025-11-13

Abstract excerpt

Background HER2-positive breast carcinomas are a heterogeneous group with various clinicopathological characteristics depending on hormone receptor (HR) status. This study aimed to analyze and compare the clinical and histopathological features of HER2-positive breast carcinomas across three subgroups: Group 1: Triple-positive (ER+/PR+/HER2+), Group 2:ER-positive only (ER+/PR-/HER2+), and Group 3: HER2-enriched (E...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6e9a95f8-e2a1-5732-8f1b-b0a499c60262
DOI: 10.12688/f1000research.171847.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Histopathological and Clinical Features of HER2-Positive Breast Cancers across Hormone Receptor Subgroups: A Cross-Sectional AnalysisDOI 10.12688/f1000research.171847.1Read

Combined Hormone Receptor and Human Epidermal Growth Factor Receptor-2 Expression Reflects Inter-and Intra-tumor Heterogeneity in Hormone Receptor-positive/human Epidermal Growth Factor Receptor-2-positive Breast CancerSemantic proximity Read

The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.Semantic proximity Read

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective studySemantic proximity Read

Epidemiological characterization of hormonal receptor profiles and associated histopathological characteristics in Rwandan women with breast cancer: a retrospective studySemantic proximity Read

Comparison of the response to neoadjuvant therapy between immunohistochemistry HER2 (3+) and HER2 (2+)/ISH-positive early- stage breast cancer: A retrospective multicenter cohort studySemantic proximity Read

Deciphering HER2 Breast Cancer Disease: Biological and Clinical ImplicationsSemantic proximity Read

Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.Semantic proximity Read

Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancerSemantic proximity Read

Ultrasound Characteristics in Predicting Molecular Subtypes of Breast Cancer: A Retrospective AnalysisSemantic proximity Read

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.Semantic proximity Read

Prognostic Impact of ER-Staining Patterns and Heterogeneity of ER positive HER2 negative Breast CancerSemantic proximity Read

Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor ExpressionSemantic proximity Read